Search Results 1521-1530 of 19472 for Myocardium

  1. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Unstable angina, myocardial infarction, coronary artery bypass graft (CABG), or stroke within 6 months prior to screening;; Left ventricle ejection fraction ...

  2. Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients - Mayo Clinic

    Evidence of non-catheter related deep vein thrombosis, stroke, myocardial infarction, or arterial embolus within the 3 months before the Day 1 Visit ...

  3. Vorinostat, Temozolomide, or Bevacizumab in Combination with Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients with Newly Diagnosed High-Grade Glioma - Mayo Clinic

    No history of myocardial infarction, severe or unstable angina, clinically significant peripheral vascular disease, ≥ grade 2 heart failure, or serious and ...

  4. Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

    Myocardial infarction within 6 months prior to enrollment, or has New York Heart Association (NYHA) class III or IV heart failure, uncontrolled angina ...

  5. RAPA-501 Therapy for ALS Expanded Access Protocol - Mayo Clinic

    Clinically significant cardiac pathology, as defined by: myocardial infarction within 6 months prior to enrollment, Class III or IV heart failure according ...

  6. A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

    Ischemia or myocardial infarct within 1 year prior to the Screening Visit;; Clinically significant atrial or ventricular dysrhythmia; the heart must be in ...

  7. A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus - Mayo Clinic

    Known history of clinically significant cardiovascular (e.g., history of myocardial infarction, congestive heart failure or uncontrolled hypertension > 90 ...

  8. Publications - Harry E. Fuentes Bayne, M.D., M.S. - Mayo Clinic

    ... myocardial infarction: Analysis of the Nationwide Inpatient Sample database 2003-2013. Vasc Med. 2019 Aug; 24 (4):341-348 Epub 2019 Mar 27. View PubMed ...

  9. A Study To Test Whether Vicadrostat (BI 690517) In Combination With Empagliflozin Helps People With Heart Failure And A Weak Pumping Function Of The Left Side Of The Heart - Mayo Clinic

    Myocardial infarction (MI), transient ischemic attack (TIA), stroke, coronary artery bypass graft surgery (CABG), heart valve surgery/intervention or any ...

  10. A Study to Evaluate Biomarker/ALK Inhibitor Combinations in Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol) - Mayo Clinic

    ... myocardial infarction within 6 months. Active and clinically significant bacterial, fungal, or viral infection. Patients with active or chronic pancreatitis ...